-
Je něco špatně v tomto záznamu ?
Affiblot: a dot blot-based screening device for selection of reliable antibodies
Z. Svobodova, J. Novotny, B. Ospalkova, M. Slovakova, Z. Bilkova, F. Foret
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
34528947
DOI
10.1039/d1ay00955a
Knihovny.cz E-zdroje
- MeSH
- ELISA MeSH
- imunoblotting MeSH
- monoklonální protilátky * MeSH
- reprodukovatelnost výsledků MeSH
- zkřížené reakce MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
The key factor in the development of antibody-based assays is to find an antibody that has an appropriate affinity, high specificity, and low cross-reactivity. However, this task is not easy to carry out since the research antibodies on the market may suffer from low specificity and reproducibility. Here, we report on a palm-sized dot blot-based device, called the affiblot, that has a specially designed lid that allows simultaneous semi-quantitative comparison of up to five antibodies from different suppliers regarding their affinity/avidity, cross-reactivity, and batch-to-batch reliability. The only required peripheral equipment is a vacuum pump, a camera, and densitometry software. The affiblot device was tested for its functionality and its measurements were compared against those obtained by standard dot blot and ELISA. The benefit over these methods, when various antibodies are evaluated, is in its simplicity. It allows easy antigen deposition, fast application and the discarding of the solutions, a compact undivided membrane, and therefore significant decrease of labor. The device was tested with specific anti-ApoE, anti-EpCAM, anti-Salmonella, anti-E. coli, and anti-Listeria antibodies from different suppliers. Their properties were compared for their ability to interact specifically with antigen and/or non-target structures and the best-suited antibody for the intended application was identified.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22003715
- 003
- CZ-PrNML
- 005
- 20220127145942.0
- 007
- ta
- 008
- 220113s2021 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1039/d1ay00955a $2 doi
- 035 __
- $a (PubMed)34528947
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Svobodova, Zuzana $u Department of Biological and Biochemical Sciences, Faculty of Chemical Technology, University of Pardubice, Studentska 573, Pardubice, Czech Republic. svobozu@faf.cuni.cz $u Department of Biological and Medical Sciences, Faculty of Pharmacy in Hradec Kralove, Charles University, Zborovska 2089, Czech Republic
- 245 10
- $a Affiblot: a dot blot-based screening device for selection of reliable antibodies / $c Z. Svobodova, J. Novotny, B. Ospalkova, M. Slovakova, Z. Bilkova, F. Foret
- 520 9_
- $a The key factor in the development of antibody-based assays is to find an antibody that has an appropriate affinity, high specificity, and low cross-reactivity. However, this task is not easy to carry out since the research antibodies on the market may suffer from low specificity and reproducibility. Here, we report on a palm-sized dot blot-based device, called the affiblot, that has a specially designed lid that allows simultaneous semi-quantitative comparison of up to five antibodies from different suppliers regarding their affinity/avidity, cross-reactivity, and batch-to-batch reliability. The only required peripheral equipment is a vacuum pump, a camera, and densitometry software. The affiblot device was tested for its functionality and its measurements were compared against those obtained by standard dot blot and ELISA. The benefit over these methods, when various antibodies are evaluated, is in its simplicity. It allows easy antigen deposition, fast application and the discarding of the solutions, a compact undivided membrane, and therefore significant decrease of labor. The device was tested with specific anti-ApoE, anti-EpCAM, anti-Salmonella, anti-E. coli, and anti-Listeria antibodies from different suppliers. Their properties were compared for their ability to interact specifically with antigen and/or non-target structures and the best-suited antibody for the intended application was identified.
- 650 12
- $a monoklonální protilátky $7 D000911
- 650 _2
- $a zkřížené reakce $7 D003429
- 650 _2
- $a ELISA $7 D004797
- 650 _2
- $a imunoblotting $7 D015151
- 650 _2
- $a reprodukovatelnost výsledků $7 D015203
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Novotny, Jakub $u Department of Biological and Biochemical Sciences, Faculty of Chemical Technology, University of Pardubice, Studentska 573, Pardubice, Czech Republic. svobozu@faf.cuni.cz $u Institute of Analytical Chemistry of the CAS, v. v. i., Veveri 967/97, Brno, Czech Republic
- 700 1_
- $a Ospalkova, Barbora $u Department of Biological and Biochemical Sciences, Faculty of Chemical Technology, University of Pardubice, Studentska 573, Pardubice, Czech Republic. svobozu@faf.cuni.cz
- 700 1_
- $a Slovakova, Marcela $u Department of Biological and Biochemical Sciences, Faculty of Chemical Technology, University of Pardubice, Studentska 573, Pardubice, Czech Republic. svobozu@faf.cuni.cz
- 700 1_
- $a Bilkova, Zuzana $u Department of Biological and Biochemical Sciences, Faculty of Chemical Technology, University of Pardubice, Studentska 573, Pardubice, Czech Republic. svobozu@faf.cuni.cz
- 700 1_
- $a Foret, Frantisek $u Institute of Analytical Chemistry of the CAS, v. v. i., Veveri 967/97, Brno, Czech Republic
- 773 0_
- $w MED00208691 $t Analytical methods : advancing methods and applications $x 1759-9679 $g Roč. 13, č. 35 (2021), s. 3874-3884
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34528947 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220113 $b ABA008
- 991 __
- $a 20220127145938 $b ABA008
- 999 __
- $a ok $b bmc $g 1751234 $s 1154864
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 13 $c 35 $d 3874-3884 $e 20210916 $i 1759-9679 $m Analytical methods $n Anal Methods $x MED00208691
- LZP __
- $a Pubmed-20220113